Jack Fosselman

Jack Fosselman is a seasoned professional with extensive experience in business development and account management. Currently serving as a Senior Key Account Manager and Senior Business Development Manager at 180 Medical since February 2023, Jack previously led business development efforts at Rx Redefined from February 2021 to January 2023, achieving a remarkable 1000% revenue increase and a 450% expansion in the customer base. Additional roles include Director of Investor Relations at Synaptogenix, Inc., and broker positions at Katalyst Securities LLC, with earlier experience as a financial advisor at Merrill Lynch Wealth Management and Edward Jones. Jack holds a Bachelor's Degree in International Business from High Point University and an Accredited Certificate from East China Normal University.